First Case: Severe Allergies in Alaska after COVID-19 Vaccination
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
- Statins Lower Blood Lipids: How Long is a Course?
- Warning: Smartwatch Blood Sugar Measurement Deemed Dangerous
First Case: Severe Allergies in Alaska after COVID-19 Vaccination
First Case: Severe Allergies in Alaska after COVID-19 Vaccination. The first case in the United States! A medical worker in Alaska has severe allergies after receiving Pfizer vaccine.
A health care worker in Alaska suffered severe allergies after being vaccinated by Pfizer. (Source: Reuters) A health care worker in Alaska has a severe allergy after being vaccinated with Pfizer. (Source: Reuters)
Overseas Network, December 17th. The US Public Health Department said on Wednesday (16th) that a medical worker in Alaska developed a severe allergic reaction after being vaccinated with Pfizer on the 15th, the first case in the United States. The medical worker has been admitted to the hospital for treatment and is currently in stable condition.
According to the New York Times, Reuters and other media reports, Lindy Jones, the chief physician of the hospital where the medical worker is located, said that the client has no history of drug allergy and it is not clear whether he has other types of allergies. According to the report, tens of millions of Americans are expected to receive the Pfizer vaccine before the end of this year. This incident may prompt US federal officials to be more vigilant about potential serious side effects of the vaccine.
Previously, the British health agency warned that people with a history of severe allergies should not get the Pfizer vaccine. They pointed out that people who have had an allergic reaction to a certain food, medicine or vaccine should not be vaccinated. They also reiterated that this response to the vaccine is “very rare.”
In the context of pressure from the White House, the US Food and Drug Administration approved the emergency use of the COVID-19 vaccine jointly developed by Pfizer and German Biotech on the 11th. On the 14th, the United States launched the COVID-19 vaccination. The first group of people to be vaccinated is medical staff and groups living in long-term care institutions such as nursing homes.
Disclaimer of medicaltrend.org
